Increasing height and body mass index are risk factors for ovarian cancer

April 3, 2012

(Medical Xpress) -- Taller women are at a greater risk of ovarian cancer, a large study has found after bringing together all the evidence from clinical studies carried out worldwide.

The analysis, led by Oxford University scientists, also found that larger body size sees a rising risk of ovarian cancer, though this effect depends on whether women have used hormone replacement therapy (HRT) or not.

The study is published in the journal PLoS Medicine and aimed to better understand some of the factors which may influence the development of ovarian cancer.

The international collaborative group, coordinated by researchers based at the Cancer Epidemiology Unit at Oxford, analyzed individual patient data from 47 epidemiological studies including over 25,000 women with ovarian cancer and more than 80,000 women without. These studies, both published and unpublished, provide virtually all the relevant data on the topic worldwide.

The researchers found a 7% increase in the risk of developing ovarian cancer for every 5 cm increase in height. For example, 165 cm-tall women have a 14% greater risk of ovarian cancer than those who are 155 cm.

'The fact that height is clearly associated with risk may well be important for understanding how ovarian cancer develops,' explained Dr Gillian Reeves of the Cancer Epidemiology Unit at Oxford University, one of the lead researchers on the study.

She added: 'Although we do not yet know why height is related to ovarian cancer risk, there are a number of possible explanations. For example, the association that we see may be due to the biological effects of factors associated with height – such as increased levels of insulin like growth factor (IGF-1) (which has been associated with a number of other cancers such as breast and prostate cancer), or increased numbers of cells being at risk of becoming cancerous. Future studies should clarify this.'

The scientists found that for body mass index (BMI) – a standard measure of body size and obesity found by dividing your weight by the square of your height – the risks of ovarian cancer depended on whether women had ever taken HRT. 

Women who have never used HRT showed a 10% increase in relative risk of ovarian cancer for every 5 kg/m2 rise in BMI.

This relationship disappeared among women who were using HRT.

Dr Reeves said: 'These results show that in women who are not taking HRT, ovarian cancer risk increases steadily with increasing BMI. These results relate only to the effect of body size on ovarian cancer risk and do not provide any relevant information about advice on HRT use.'

The researchers say that unlike height, BMI is something that people can potentially do something about and this may be relevant for health advice for cancer prevention. But their main focus is on understanding the biological pathways connected to ovarian cancer.

Dr Reeves notes that women’s oestrogen levels are linked to the amount of body fat they have, at least in postmenopausal women who aren’t using HRT: 'We think this may be part of the explanation for the association between BMI and ovarian cancer,' she said.

Oestrogen levels are also likely to be altered with HRT, and this may explain why there is a different effect of BMI in HRT users.

The average height and BMI of women in Western countries have been increasing by about 1 cm and 1 kg/m2 per decade, respectively.

The findings of this study suggest that these increases in height and weight would have resulted in the number of ovarian cancer cases rising by 3% per decade, if all other factors affecting ovarian cancer risk remained constant.  

Sarah Williams, health information officer at Cancer Research UK, which funded the work, said: 'This study included as much evidence as possible to produce a clearer picture of the factors that can affect a woman's risk of developing ovarian cancer, and found that body size was important. Women can reduce their risk of this and many other diseases by keeping to a healthy weight. For women trying to lose weight, the best method is to eat healthily, eat smaller amounts and be more physically active.'

More information: Collaborative Group on Epidemiological Studies of Ovarian Cancer (2012) Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies. PLoS Med 9(4): e1001200. doi:10.1371/journal.pmed.1001200

Related Stories

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.